The search for APhA’s next CEO has launched with the release of the CEO position specification by the APhA Executive Committee, Search Committee, and executive search firm, Russell Reynolds Associates.
Categories: Press Releases
Tags: Press Releases, press release
Yesterday, FDA announced modifications to the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone (Mifeprex–Danco Labs) that enable pharmacies to become certified to dispense this FDA-approved drug to patients with a prescription, as long as they comply with the certification requirements.
WASHINGTON, D.C. – The American Pharmacists Association (APhA) hailed the Federal Trade Commission’s (FTC) statement restoring the agency’s policy of rigorously enforcing the federal ban on unfair methods of competition
WASHINGTON, D.C. – The American Pharmacists Association (APhA) today hailed the release of a peer-reviewed study that found that community-based pharmacists and their teams administered more than 270 million COVID-19 vaccinations in community pharmacies alone through September 2022.
Washington, DC — Today, APhA released the following statement regarding the CDC’s Updated Pain Management Guidelines.